Selective ligands for lysophosphatidic acid receptor subtypes: Gaining control over the endothelial differentiation gene family

Molecular Pharmacology

Volumn 60, Issue 6, 2001, Pages 1161-1164

  Tigyi, G ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR AGONIST; LYSOPHOSPHATITIC ACID RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL SURVIVAL; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0035210589     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.6.1161     Document Type: Short Survey

References (51)

1. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid
2. Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids
3. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization
4. A novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid with unsaturated fatty-acid moiety
5. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry
6. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo
7. Proinflammatory macrophage-activating properties of the novel phospholipid diacylglycerol pyrophosphate
8. Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors
9. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
10. A short synthesis of lipid phosphoric acids analogues inhibiting the lysophosphatidate receptor
11. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior
12. Lysophosphatidic acid receptors
13. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase D and phospholipase A2
14. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer
15. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes
16. Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors
17. Peptide and lipid growth factors decrease cisdiamminedichloroplatinum-induced cell death in human ovarian cancer cells
18. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax
19. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue
20. Molecular cloning of a high affinity receptor for the growth factor-like phospholipid mediator lysophosphatidic acid
21. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids
22. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
23. 3 receptor antagonist
24. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors
25. Characterization of a receptor subtype-selective lysophosphatidic acid mimetic
26. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent
27. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8
28. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
29. Induction of in vitro tumor cell invasion of cellular monolayers by lysphosphatidic acid or phospholipase D
30. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3
31. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: Similarity to thrombin action
32. 2+ mobilization in human A431 cells: Structure-activity analysis
33. N-palmitoyl-serine- and N-palmitoyl-phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors
34. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
35. Bioactive lysophospholipids and their G protein-coupled receptors
36. Structural features of EDG1 receptor-ligand complexes revealed by computational modeling and mutagenesis
37. Identification of Edg1 receptor residues that recognize sphingosine 1- phosphate
38. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
39. Sphingosine 1-phosphate signalling in mammalian cells
40. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction
41. Diacyl-(8:0)-glycerolpyrophosphate, a new Edg-receptor antagonist, blocks LPA-induced shape change in human platelets
42. Molecular basis for lysophosphatidic acid receptor antagonist selectivity
43. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
44. Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: A new group of phospholipid mediators?
45. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: Comparison with platelet activating factor
46. Physiological responses to lysophosphatidic acid and related glycerophospholipids
47. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytema cells
48. 1 (EDG2) phospholipid growth factor receptors
49. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid
50. Lysophospholipids activate ovarian and breast cancer cells
51. Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride